TSE:HBP

Helix BioPharma (HBP) Stock Forecast, Price & News

C$0.21

+0.01 (+5.00%)

(As of 05/20/2022 12:00 AM ET)

Add

Compare

Today's Range: C$0.19
▼
C$0.21
50-Day Range: C$0.18
▼
C$0.25
52-Week Range: C$0.17
▼
C$0.97

Volume: 27,850 shs
Average Volume: 30,044 shs
Market Capitalization: C$32.34 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive HBP News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

About Helix BioPharma

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.

May 17, 2022 | finance.yahoo.com

Insiders may be rethinking their CA$3.0m Helix BioPharma Corp. (TSE:HBP) investment now that the company has lost CA$5.0m in value

April 22, 2022 | finance.yahoo.com

Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.

April 18, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

April 18, 2022 | finance.yahoo.com

Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

April 7, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Announces Board Resignation

March 22, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Management and Board Changes

March 22, 2022 | finance.yahoo.com

Helix Biopharma Corp. Announces Management and Board Changes

March 16, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results

March 16, 2022 | proactiveinvestors.com

Helix BioPharma announces sudden passing of interim CEO Slawomir Majewski

March 11, 2022 | apnews.com

Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

March 11, 2022 | finance.yahoo.com

Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

March 11, 2022 | finance.yahoo.com

CORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

December 31, 2021 | ca.finance.yahoo.com

Stocks in play: Helix BioPharma Corp

See More Headlines

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:HBP
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.helixbiopharma.com
Phone: +1-416-9253232
Fax: N/A
Employees: 10
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.00 per share
Price / Cash Flow: 63.33
Book Value: C($0.03) per share
Price / Book: -7.24

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 2.60
Current Ratio: 0.23
Quick Ratio: 0.20

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 154,021,000
Free Float: N/A
Market Cap: C$32.34 million
Optionable: Optionable

Company Calendar

Last Earnings: 3/16/2022
Today: 5/22/2022
Next Earnings (Estimated): 6/13/2022

MarketRank^™

Overall MarketRank^™

0.85 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Helix BioPharma.

4.3 Community Rank

Outperform Votes
Helix BioPharma has received 66 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Helix BioPharma has received 38 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Helix BioPharma has received 63.46% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Helix BioPharma and other stocks. Vote “Outperform” if you believe HBP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HBP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Helix BioPharma does not currently pay a dividend.
Dividend Growth
Helix BioPharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Helix BioPharma insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Helix BioPharma is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Helix BioPharma is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Helix BioPharma (TSE:HBP) Frequently Asked Questions

When is Helix BioPharma's next earnings date?: Helix BioPharma is scheduled to release its next quarterly earnings announcement on Monday, June 13th 2022.
View our earnings forecast for Helix BioPharma.
How were Helix BioPharma's earnings last quarter?: Helix BioPharma Corp. (TSE:HBP) posted its earnings results on Wednesday, March, 16th. The biopharmaceutical company reported ($0.01) earnings per share for the quarter.
View Helix BioPharma's earnings history.
Who are Helix BioPharma's key executives?: Helix BioPharma's management team includes the following people:
Mr. Artur Gabor, CEO & Chairman (Age 62, Pay $60k)
Mr. Photios Michalargias C.A., CPA, CA, CPA, Chief Financial Officer (Age 59, Pay $285.87k)
Who are some of Helix BioPharma's key competitors?: Some companies that are related to Helix BioPharma include Aptose Biosciences (APS), Faron Pharmaceuticals Oy (FARN), Tiziana Life Sciences (TILS), Novacyt (NCYT), Verseon (VSN), IMV (IMV), Arecor Therapeutics (AREC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Scancell (SCLP), e-therapeutics (ETX), Novoheart (NVH), Open Orphan (ORPH), Mereo BioPharma Group plc (MPH.L) (MPH) and Burcon NutraScience (BU).
View all of HBP's competitors.
What other stocks do shareholders of Helix BioPharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma investors own include Lakeland Industries (LAKE), Liquidia (LQDA), Ovintiv (OVV), SIG (SHI), Green Organic Dutchman (TGOD), Zynerba Pharmaceuticals (ZYNE), American Airlines Group (AAL), Aurora Cannabis (ACB), Apollo Investment (AINV) and Aphria (APHA).
What is Helix BioPharma's stock symbol?: Helix BioPharma trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HBP."
How do I buy shares of Helix BioPharma?: Shares of HBP and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Helix BioPharma's stock price today?: One share of HBP stock can currently be purchased for approximately C$0.21.
How much money does Helix BioPharma make?: Helix BioPharma has a market capitalization of C$32.34 million.
How many employees does Helix BioPharma have?: Helix BioPharma employs 10 workers across the globe.
What is Helix BioPharma's official website?: The official website for Helix BioPharma is www.helixbiopharma.com.
How can I contact Helix BioPharma?: Helix BioPharma's mailing address is 21 St Clair Ave E Suite 1100, TORONTO, ON M4T 1L9, Canada. The biopharmaceutical company can be reached via phone at +1-416-9253232.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.